Hàn Quốc cấp phép khẩn cấp thuốc molnupiravir điều trị COVID-19

Theo Yonhap 21:04 23/03/2022

Trong nỗ lực giảm ca bệnh nặng và tử vong do COVID-19, cơ quan an toàn dược phẩm của Hàn Quốc ngày 23/3 đã cấp phép khẩn cấp thuốc molnupiravir của hãng Merck & Co Inc để điều trị cho người trưởng thành mắc COVID-19.

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